Hàn Quốc cấp phép khẩn cấp thuốc molnupiravir điều trị COVID-19

Theo Yonhap 21:04 23/03/2022

Trong nỗ lực giảm ca bệnh nặng và tử vong do COVID-19, cơ quan an toàn dược phẩm của Hàn Quốc ngày 23/3 đã cấp phép khẩn cấp thuốc molnupiravir của hãng Merck & Co Inc để điều trị cho người trưởng thành mắc COVID-19.

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